Hàn Quốc cấp phép khẩn cấp thuốc molnupiravir điều trị COVID-19

Theo Yonhap 21:04 23/03/2022

Trong nỗ lực giảm ca bệnh nặng và tử vong do COVID-19, cơ quan an toàn dược phẩm của Hàn Quốc ngày 23/3 đã cấp phép khẩn cấp thuốc molnupiravir của hãng Merck & Co Inc để điều trị cho người trưởng thành mắc COVID-19.

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